Hàn Quốc cấp phép khẩn cấp thuốc molnupiravir điều trị COVID-19

Theo Yonhap 21:04 23/03/2022

Trong nỗ lực giảm ca bệnh nặng và tử vong do COVID-19, cơ quan an toàn dược phẩm của Hàn Quốc ngày 23/3 đã cấp phép khẩn cấp thuốc molnupiravir của hãng Merck & Co Inc để điều trị cho người trưởng thành mắc COVID-19.

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